Hàn Quốc cấp phép khẩn cấp thuốc molnupiravir điều trị COVID-19

Theo Yonhap 21:04 23/03/2022

Trong nỗ lực giảm ca bệnh nặng và tử vong do COVID-19, cơ quan an toàn dược phẩm của Hàn Quốc ngày 23/3 đã cấp phép khẩn cấp thuốc molnupiravir của hãng Merck & Co Inc để điều trị cho người trưởng thành mắc COVID-19.

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